TP53 missense–specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer
- Journal:
- Science Advances
- Published:
- Affiliations:
- 9
- Authors:
- 14
| Institutions | Authors | Share |
|---|---|---|
| University Medical Center Göttingen (UMG), Germany | 0.86 | |
| Cancer Research Center of Marseille (CRCM), France | 0.07 | |
| Ulm University Medical Center, Germany | 0.04 | |
| Max Planck Institute for Multidisciplinary Sciences, Germany | 0.04 |